Michael Widlitz's most recent trade in Immunome Inc was a trade of 3,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Michael Widlitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Widlitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Widlitz | Director | 06 Oct 2020 | 51,315 | 51,315 | - | - | Common Stock | ||
| Immunome Inc | Michael Widlitz | Director | 06 Oct 2020 | 51,315 | 0 | - | - | Series A Convertible Preferred Stock |